Jordi Olloquequi at University of Barcelona - Research Interests, Publications & Academic Profile

Jordi Olloquequi

Lecturer

University of Barcelona

Spain

Has grant

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do Turkish students reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Pharmacology

60%

Pharmacotherapy

30%

Neuropharmacology

50%

Alzheimer's Disease

40%

Neurochemistry

30%

Neuroprotection

30%

Lung Disease

20%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Recent Grants

Grant: Close

Analysis Of Inflammatory And Autoimmunity-Related Genes In Chilean Individuals With Chronic Obstructive Pulmonary Disease

Open Date:

Close Date:

Articles17

From Inhalation to Neurodegeneration: Air Pollution as a Modifiable Risk Factor for Alzheimer’s Disease

Article Link

Year:

2024

Unveiling the Significance of HLA and KIR Diversity in Underrepresented Populations

Article Link

Year:

2024

JNK signaling and its impact on neural cell maturation and differentiation

Article Link

Year:

2024

Licochalcone A: A Potential Multitarget Drug for Alzheimer’s Disease Treatment

Article Link

Year:

2023

Gallbladder Cancer Risk and Indigenous South American Mapuche Ancestry: Instrumental Variable Analysis Using Ancestry-Informative Markers

Article Link

Year:

2023

A novel rhein-huprine hybrid ameliorates disease-modifying properties in preclinical mice model of Alzheimer's disease exacerbated with high fat diet.

Article Link

Year:

2023

Caffeic Acid Phenethyl Ester (CAPE): Biosynthesis, Derivatives and Formulations with Neuroprotective Activities

Article Link

Year:

2023

Development and internal validation of a multifactorial risk prediction model for gallbladder cancer in a high-incidence country

Article Link

Year:

2023

Pharmacogenetic Variation and Its Clinical Relevance in a Latin American Rural Population

Article Link

Year:

2022

Protein tyrosine phosphatase 1B (PTP1B) as a potential therapeutic target for neurological disorders.

Article Link

Year:

2022

Peroxisomal Proliferator-Activated Receptor <i>β</i>/<i>δ</i> Deficiency Induces Cognitive Alterations.

Article Link

Year:

2022

Impact of New Drugs for Therapeutic Intervention in Alzheimer's Disease.

Article Link

Year:

2022

JNK1 and JNK3: divergent functions in hippocampal metabolic-cognitive function.

Article Link

Year:

2022

Polymorphisms in the FRMD4A Gene Are Associated With Chronic Obstructive Pulmonary Disease Susceptibility in a Latin American Population.

Article Link

Year:

2022

Identification of Circulating lncRNAs Associated with Gallbladder Cancer Risk by Tissue-Based Preselection, Cis-eQTL Validation, and Analysis of Association with Genotype-Based Expression.

Article Link

Year:

2022

The Cross Talk between Underlying Mechanisms of Multiple Sclerosis and Epilepsy May Provide New Insights for More Efficient Therapies

Article Link

Year:

2021

Decreased Expression of EC-SOD and Fibulin-5 in Alveolar Walls of Lungs From COPD Patients,Expresión disminuida de SOD3 y fibulina-5 en las paredes alveolares de los pulmones en pacientes con EPOC

Article Link

Year:

2021

Collaborators7

Elena Sánchez-López

University of Barcelona

SPAIN

Diego Muñoz-Torrero

Full Professor of Organic & Medicinal Chemistry

University of Barcelona

SPAIN

Amanda Cano

Head of Molecular Biology & Biomarkers program

SPAIN

Joana Bicker

Invited Assistant Professor

Faculty of Pharmacy, University of Lisbon

PORTUGAL

Miren Ettcheto

Profesor lector

University of Barcelona

SPAIN

Justo Lorenzo Bermejo

Heidelberg University

GERMANY

Ana Fortuna

Professor

Faculty of Pharmacy, University of Lisbon

PORTUGAL

How do Turkish students reach out?

Meet Kite AI